DE60326468D1 - Neue aryl-4-halogen-4-(heteroarylmethylamino)methyl piperidin-1-yl-methanonderivate, herstellungsverfahren und deren verwendung als medikamente - Google Patents
Neue aryl-4-halogen-4-(heteroarylmethylamino)methyl piperidin-1-yl-methanonderivate, herstellungsverfahren und deren verwendung als medikamenteInfo
- Publication number
- DE60326468D1 DE60326468D1 DE60326468T DE60326468T DE60326468D1 DE 60326468 D1 DE60326468 D1 DE 60326468D1 DE 60326468 T DE60326468 T DE 60326468T DE 60326468 T DE60326468 T DE 60326468T DE 60326468 D1 DE60326468 D1 DE 60326468D1
- Authority
- DE
- Germany
- Prior art keywords
- heteroarylmethylamino
- methylpiperidin
- medicaments
- halogen
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KDISMIMTGUMORD-UHFFFAOYSA-N 1-acetylpiperidine Chemical class CC(=O)N1CCCCC1 KDISMIMTGUMORD-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207470A FR2840900B1 (fr) | 2002-06-18 | 2002-06-18 | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| PCT/FR2003/001873 WO2003106449A1 (fr) | 2002-06-18 | 2003-06-18 | Nouveaux derives d'aryl-{4-halogeno-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60326468D1 true DE60326468D1 (de) | 2009-04-16 |
Family
ID=29595331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60326468T Expired - Lifetime DE60326468D1 (de) | 2002-06-18 | 2003-06-18 | Neue aryl-4-halogen-4-(heteroarylmethylamino)methyl piperidin-1-yl-methanonderivate, herstellungsverfahren und deren verwendung als medikamente |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7547700B2 (https=) |
| EP (1) | EP1539738B1 (https=) |
| JP (1) | JP4699027B2 (https=) |
| CN (1) | CN1308325C (https=) |
| AT (1) | ATE424396T1 (https=) |
| AU (1) | AU2003258816B2 (https=) |
| BR (1) | BRPI0311976B8 (https=) |
| CA (1) | CA2489723C (https=) |
| DE (1) | DE60326468D1 (https=) |
| ES (1) | ES2321927T3 (https=) |
| FR (1) | FR2840900B1 (https=) |
| MX (1) | MXPA05000024A (https=) |
| WO (1) | WO2003106449A1 (https=) |
| ZA (1) | ZA200500467B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2852244B1 (fr) * | 2003-03-13 | 2007-09-07 | Pf Medicament | Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene |
| FR2891274B1 (fr) * | 2005-09-27 | 2007-11-23 | Pierre Fabre Medicament Sa | Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires. |
| US8389534B2 (en) * | 2008-05-19 | 2013-03-05 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| WO2009143183A1 (en) * | 2008-05-19 | 2009-11-26 | University Of Tennessee Research Foundation, The | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| FR2946344B1 (fr) | 2009-06-05 | 2012-05-25 | Pf Medicament | Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| EP2338873A1 (en) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | New aminotetraline derivatives |
| WO2018057576A1 (en) * | 2016-09-22 | 2018-03-29 | Auspex Pharmaceuticals, Inc. | Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds |
| WO2019016357A1 (en) | 2017-07-20 | 2019-01-24 | Neurolixis | USE OF SELECTIVE 5-HT1A SEROTONIN RECEPTOR AGONISTS TO TREAT THE ADVERSE EFFECTS OF VMAT INHIBITORS |
| WO2023144166A1 (en) | 2022-01-26 | 2023-08-03 | Neurolixis | Use of serotonin 5-ht1a receptor agonists to treat diseases associated with sudden unexpected death in epilepsy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN169588B (https=) * | 1986-10-07 | 1991-11-16 | Pfizer Hospital Prod | |
| FR2755967B1 (fr) * | 1996-11-21 | 1999-01-29 | Pf Medicament | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
| FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| FR2820743B1 (fr) * | 2001-02-09 | 2005-02-25 | Pf Medicament | Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine |
-
2002
- 2002-06-18 FR FR0207470A patent/FR2840900B1/fr not_active Expired - Lifetime
-
2003
- 2003-06-18 AU AU2003258816A patent/AU2003258816B2/en not_active Expired
- 2003-06-18 CN CNB038186047A patent/CN1308325C/zh not_active Expired - Lifetime
- 2003-06-18 AT AT03760060T patent/ATE424396T1/de not_active IP Right Cessation
- 2003-06-18 ES ES03760060T patent/ES2321927T3/es not_active Expired - Lifetime
- 2003-06-18 BR BRPI0311976A patent/BRPI0311976B8/pt not_active IP Right Cessation
- 2003-06-18 EP EP03760060A patent/EP1539738B1/fr not_active Expired - Lifetime
- 2003-06-18 WO PCT/FR2003/001873 patent/WO2003106449A1/fr not_active Ceased
- 2003-06-18 MX MXPA05000024A patent/MXPA05000024A/es active IP Right Grant
- 2003-06-18 DE DE60326468T patent/DE60326468D1/de not_active Expired - Lifetime
- 2003-06-18 CA CA2489723A patent/CA2489723C/fr not_active Expired - Lifetime
- 2003-06-18 US US10/518,394 patent/US7547700B2/en not_active Expired - Lifetime
- 2003-06-18 JP JP2004513281A patent/JP4699027B2/ja not_active Expired - Lifetime
-
2005
- 2005-01-18 ZA ZA2005/00467A patent/ZA200500467B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2489723A1 (fr) | 2003-12-24 |
| EP1539738B1 (fr) | 2009-03-04 |
| JP2005534668A (ja) | 2005-11-17 |
| US7547700B2 (en) | 2009-06-16 |
| CN1675194A (zh) | 2005-09-28 |
| ATE424396T1 (de) | 2009-03-15 |
| HK1075452A1 (en) | 2005-12-16 |
| AU2003258816B2 (en) | 2008-08-21 |
| US20060100244A1 (en) | 2006-05-11 |
| CN1308325C (zh) | 2007-04-04 |
| FR2840900B1 (fr) | 2005-02-25 |
| ES2321927T3 (es) | 2009-06-15 |
| AU2003258816A1 (en) | 2003-12-31 |
| BRPI0311976B1 (pt) | 2015-08-18 |
| WO2003106449A1 (fr) | 2003-12-24 |
| BRPI0311976B8 (pt) | 2021-05-25 |
| EP1539738A1 (fr) | 2005-06-15 |
| MXPA05000024A (es) | 2005-04-08 |
| CA2489723C (fr) | 2011-08-02 |
| ZA200500467B (en) | 2005-12-28 |
| BR0311976A (pt) | 2005-03-29 |
| WO2003106449A8 (fr) | 2005-02-17 |
| JP4699027B2 (ja) | 2011-06-08 |
| FR2840900A1 (fr) | 2003-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004037811A8 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| DE60221969D1 (de) | Durch piperidine-enthaltende gruppen substituierte chinoline und deren stickstoff-enthaltende derivate und ihre verwendung als antibakterielle wirkstoffe | |
| NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
| DE60326468D1 (de) | Neue aryl-4-halogen-4-(heteroarylmethylamino)methyl piperidin-1-yl-methanonderivate, herstellungsverfahren und deren verwendung als medikamente | |
| ATE490253T1 (de) | Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen | |
| ATE496893T1 (de) | Isochinolinonderivate und deren verwendung als medikamente | |
| ATE359286T1 (de) | Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika | |
| NO20064077L (no) | Kemokinreseptorantagonister | |
| SE0202465D0 (sv) | New compounds | |
| ATE422198T1 (de) | Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten | |
| NO20054852L (no) | GFAT inhibitorer | |
| ATE498618T1 (de) | Neue zyklische harnstoffderivate, deren herstellung und pharmazeutische verwendung damit als kinase-inhibitoren | |
| CY1115162T1 (el) | Νεα μεθοδος βιομηχανικης συνθεσης του ρανελικου στροντιου και των ενυδρων αλατων του | |
| ATE349412T1 (de) | Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten | |
| ATE373009T1 (de) | Verfahren zur vorbereitung von telithromycin | |
| ATE444747T1 (de) | Verfahren zur herstellung von expoxybutanol- zwischenprodukten | |
| DE60203481D1 (de) | Piperidinderivate als neurokinin 1 antagonisten | |
| DE602005011593D1 (de) | Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten | |
| ATE525364T1 (de) | Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten | |
| EP1489890A4 (en) | ORGANIC ELECTROLUMINESCENCE TABLE AND METHOD FOR THE PRODUCTION THEREOF | |
| EA200700146A1 (ru) | Кристаллизированный полиэтилентерефталат, содержащий кремний, и способ его получения | |
| ATE461924T1 (de) | Verfahren zur herstellung von rosuvastatin und intermediate | |
| SG165416A1 (en) | Chemical process | |
| ATE495158T1 (de) | Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
| DE60331762D1 (de) | Neue piperidinderivate und deren verwendung als monoaminneurotransmitter-wiederaufnahmehemmer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |